Serbian Drugmaker Galenika to Cut Jobs, Wages to Post Profits

Galenika AD Zemun, a Serbian state-owned drugmaker, needs to cut 800 jobs and lower wages by 20 percent to return to profit, the Finance Ministry said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.